quetiapine has been researched along with norclozapine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sen, S; Sinha, N | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Horiguchi, M; Ishida, K; Isobe, Y; Nakako, T; Watanabe, H; Yamamoto, M | 1 |
3 other study(ies) available for quetiapine and norclozapine
| Article | Year |
|---|---|
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Azepines; Cholinergic Agents; Clozapine; Dopamine; Drug Evaluation, Preclinical; Humans; Mice; Olanzapine; Protein Binding; Quetiapine Fumarate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Serotonin; Small Molecule Libraries; Structure-Activity Relationship | 2021 |